Patent · US Active

Method for inducing targeted meiotic recombinations

US11248240B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 29, 2016
Grant dateFeb 15, 2022
Priority date
Expiry dateJan 29, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02E50/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a fusion protein comprising a Cas9 domain and a Spo11 domain, as well as the use of this protein to induce targeted meiotic recombinations in a eukaryotic cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.